FI834806A0 - 1-cyklopropyl-6-fluor-1,4-dihydro-4-oxo-7-(alkyl)-1-piperazinyl)-3-kinolinkarboxylsyror, foerfarande foer deras framstaellning och dessa innehaollande antibakteriella produkter - Google Patents

1-cyklopropyl-6-fluor-1,4-dihydro-4-oxo-7-(alkyl)-1-piperazinyl)-3-kinolinkarboxylsyror, foerfarande foer deras framstaellning och dessa innehaollande antibakteriella produkter

Info

Publication number
FI834806A0
FI834806A0 FI834806A FI834806A FI834806A0 FI 834806 A0 FI834806 A0 FI 834806A0 FI 834806 A FI834806 A FI 834806A FI 834806 A FI834806 A FI 834806A FI 834806 A0 FI834806 A0 FI 834806A0
Authority
FI
Finland
Prior art keywords
piperazinyl
cyclopropyl
dihydro
oxo
fluoro
Prior art date
Application number
FI834806A
Other languages
English (en)
Other versions
FI79102C (fi
FI834806A (fi
FI79102B (fi
Inventor
Uwe Petersen
Klaus Grohe
Hans-Joachim Zeiler
Karl Georg Metzger
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6182078&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI834806(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI834806A0 publication Critical patent/FI834806A0/fi
Publication of FI834806A publication Critical patent/FI834806A/fi
Application granted granted Critical
Publication of FI79102B publication Critical patent/FI79102B/fi
Publication of FI79102C publication Critical patent/FI79102C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI834806A 1982-12-29 1983-12-27 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1-cyklopropyl-6-fluor-1,4-dihydro-4-oxo-7- (alkyl-1-piperazinyl)-3-kinolinkarboxylsyraderivat. FI79102C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3248506 1982-12-29
DE19823248506 DE3248506A1 (de) 1982-12-29 1982-12-29 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7(alkyl-1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel

Publications (4)

Publication Number Publication Date
FI834806A0 true FI834806A0 (fi) 1983-12-27
FI834806A FI834806A (fi) 1984-06-30
FI79102B FI79102B (fi) 1989-07-31
FI79102C FI79102C (fi) 1989-11-10

Family

ID=6182078

Family Applications (1)

Application Number Title Priority Date Filing Date
FI834806A FI79102C (fi) 1982-12-29 1983-12-27 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1-cyklopropyl-6-fluor-1,4-dihydro-4-oxo-7- (alkyl-1-piperazinyl)-3-kinolinkarboxylsyraderivat.

Country Status (20)

Country Link
US (1) US4544658A (fi)
EP (1) EP0113093B1 (fi)
JP (1) JPS59130880A (fi)
KR (2) KR870000901B1 (fi)
AT (1) ATE19877T1 (fi)
AU (1) AU560153B2 (fi)
CA (1) CA1218070A (fi)
DD (1) DD216016A5 (fi)
DE (2) DE3248506A1 (fi)
DK (1) DK160989C (fi)
ES (1) ES8406846A1 (fi)
FI (1) FI79102C (fi)
GR (1) GR79445B (fi)
HU (1) HU191392B (fi)
IE (1) IE56460B1 (fi)
IL (1) IL70539A (fi)
NO (1) NO162236C (fi)
NZ (1) NZ206705A (fi)
PH (3) PH20545A (fi)
ZA (1) ZA839646B (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468861A (en) * 1984-06-04 1995-11-21 Bayer Aktiengesellschaft 8-chloro-1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid and alkyl esters thereof
DE3420743A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3420798A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-(3-aryl-l-piperazinyl)- sowie 7-(3-cyclohexyl-l-piperazinyl)-3-chinoloncarbonsaeuren
DE3420770A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-(3-oxo-1-piperazinyl)-3-chinoloncarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3426483A1 (de) * 1984-07-18 1986-01-30 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von halogenierten chinoloncarbonsaeuren
DE3435392A1 (de) * 1984-09-27 1986-04-03 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 2,4-dichlor-5-fluor-benzoesaeure
JPS6191183A (ja) * 1984-10-11 1986-05-09 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
US4636506A (en) * 1984-12-06 1987-01-13 Pfizer, Inc. 7-heterocyclic-1,4-dihydroquinolones
EP0191185B1 (en) * 1984-12-14 1990-03-07 Daiichi Seiyaku Co., Ltd. Quinoline-carboxylic acid derivatives
DE3508816A1 (de) * 1985-01-10 1986-07-10 Bayer Ag, 5090 Leverkusen 6,7-disubstituierte 1-cyclopropyl-1,4-dihydro-4-oxo-1,8-naphtyridin-3-carbonsaeuren
DE3509546A1 (de) * 1985-03-16 1986-09-25 Bayer Ag, 5090 Leverkusen 7-amino-1-(subst.cyclopropyl)-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
AU594983B2 (en) 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
DE3617803A1 (de) * 1985-11-07 1987-11-19 Bayer Ag Verwendung von gyrasehemmern zur dekontamination von mycoplasma-infizierten zellkulturen
DE3542002A1 (de) * 1985-11-28 1987-06-04 Bayer Ag 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4977154A (en) * 1985-12-12 1990-12-11 Warner-Lambert Company 5-amino and 5-hydroxy-6-fluoroquinolones as antibacterial agents
US5210193A (en) * 1986-01-17 1993-05-11 American Cyanamid Company Piperazine derivatives
US4940710A (en) * 1986-01-17 1990-07-10 American Cyanamid Company 7-(substituted)piperazinyl-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
JPS62215572A (ja) * 1986-03-17 1987-09-22 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
US5164392A (en) * 1987-10-16 1992-11-17 Dainippon Pharmaceutical Co., Ltd. Quinoline derivatives and antibacterial agent containing them
IL88003A (en) * 1987-10-16 1992-11-15 Dainippon Pharmaceutical Co Quinoline derivatives,their preparation and pharmaceutical compositions containing them
CZ12097A3 (en) * 1994-07-18 1997-09-17 Ube Industries Trifluoromethylquinolinecarboxylic acid derivatives and pharmaceutical composition containing thereof
JP3449658B2 (ja) * 1994-12-21 2003-09-22 杏林製薬株式会社 安定性に優れた8−アルコキシキノロンカルボン酸水和物並びにその製造方法
US6387928B1 (en) * 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
HUP0100051A3 (en) * 1997-09-15 2002-08-28 Procter & Gamble Antimicrobial quinolones, their compositions and uses
KR100821894B1 (ko) * 2004-07-02 2008-04-16 주식회사 코오롱 항균 염료 및 그를 이용한 항균 섬유
JP4876165B2 (ja) * 2006-03-28 2012-02-15 ザ プロクター アンド ギャンブル カンパニー キノロン中間体を調製するための水素化物還元法
JP2009531418A (ja) * 2006-03-28 2009-09-03 ザ プロクター アンド ギャンブル カンパニー キノロン中間体調製のためのカップリング方法
WO2007110834A2 (en) * 2006-03-28 2007-10-04 The Procter & Gamble Company Malate salts, and polymorphs of (3s,5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3149104A (en) * 1961-01-03 1964-09-15 Sterling Drug Inc 4-hydroxy-7-styryl-1, 8-naphthyridine-3-carboxylic acids and esters
DE2808070A1 (de) * 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel

Also Published As

Publication number Publication date
KR870000901B1 (ko) 1987-05-04
NO834632L (no) 1984-07-02
EP0113093B1 (de) 1986-05-21
ZA839646B (en) 1984-08-29
JPH0323549B2 (fi) 1991-03-29
DK604083D0 (da) 1983-12-28
AU560153B2 (en) 1987-04-02
GR79445B (fi) 1984-10-30
IL70539A (en) 1987-08-31
DE3363608D1 (en) 1986-06-26
ES528495A0 (es) 1984-09-01
KR840006990A (ko) 1984-12-04
NO162236B (no) 1989-08-21
US4544658A (en) 1985-10-01
JPS59130880A (ja) 1984-07-27
DK604083A (da) 1984-06-30
ES8406846A1 (es) 1984-09-01
EP0113093A1 (de) 1984-07-11
AU2251083A (en) 1984-07-05
KR870001003B1 (ko) 1987-05-18
DE3248506A1 (de) 1984-07-05
IL70539A0 (en) 1984-03-30
PH20545A (en) 1987-02-09
HU191392B (en) 1987-02-27
DK160989C (da) 1991-10-28
CA1218070A (en) 1987-02-17
PH21478A (en) 1987-10-28
FI79102C (fi) 1989-11-10
NO162236C (no) 1989-11-29
NZ206705A (en) 1986-01-24
FI834806A (fi) 1984-06-30
ATE19877T1 (de) 1986-06-15
IE833034L (en) 1984-06-29
DD216016A5 (de) 1984-11-28
DK160989B (da) 1991-05-13
IE56460B1 (en) 1991-08-14
PH22453A (en) 1988-09-12
FI79102B (fi) 1989-07-31

Similar Documents

Publication Publication Date Title
FI834806A0 (fi) 1-cyklopropyl-6-fluor-1,4-dihydro-4-oxo-7-(alkyl)-1-piperazinyl)-3-kinolinkarboxylsyror, foerfarande foer deras framstaellning och dessa innehaollande antibakteriella produkter
SE8100978L (sv) Kinolinkarboxylsyraderivat och sett for framstellning derav
SE7908065L (sv) Substituerade kinolinkarboxylsyraderivat
ATE19876T1 (de) 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-(4de821229
FR2381762A1 (fr) Dibenzodiazepines utilisables comme antischizophreniques
IT1198333B (it) Procedimento per la preparazione di composizioni di olio lubrificante contenenti composti di molibdeno antiossidanti
IT8023093A0 (it) Procedimento per la preparazione di composizioni di olio lubrificante contenenti composti di molibdeno come additivi antiossidanti.
DK299382A (da) Antibiotisk virksomme forbindelser deres fremstilling og anvendelse
IT1127292B (it) Procedimento per la preparazione di composizioni additive per olii lubrificanti,composizioni relative e concentrati contenenti detti additivi

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: BAYER AKTIENGESELLSCHAFT